NovaBridge Biosciences: net_income
| Value | {"amount": -208560000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9b060ace-8424-40a8-8f0a-77a72a6c6737
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-20-124785Retrieved: 2026-08-19T18:00:43.919806+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/net-income/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9b060ace-8424-40a8-8f0a-77a72a6c6737
History
- supersedes {"unit": "CNY", "value": -1451950000, "concept": "us-gaap:NetIncomeLoss"} (evidence 0001193125-20-124785)